Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd bought 5,000,000 shares of the stock in a transaction that occurred on Thursday, January 22nd. The stock was bought at an average price of $5.75 per share, with a total value of $28,750,000.00. Following the completion of the purchase, the insider directly owned 13,219,814 shares in the company, valued at $76,013,930.50. This represents a 60.83% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Anteris Technologies Global Trading Up 2.2%
Anteris Technologies Global stock traded up $0.12 during trading on Monday, reaching $5.61. 692,120 shares of the company were exchanged, compared to its average volume of 2,132,993. Anteris Technologies Global Corp. has a 52-week low of $2.34 and a 52-week high of $8.79. The company has a market capitalization of $231.13 million, a P/E ratio of -3.10 and a beta of 1.29. The stock’s 50 day simple moving average is $5.25 and its two-hundred day simple moving average is $4.61. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.84 and a quick ratio of 0.80.
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.05). The business had revenue of $0.43 million during the quarter, compared to analyst estimates of $0.74 million. Anteris Technologies Global had a negative net margin of 3,944.93% and a negative return on equity of 252.71%. On average, equities research analysts expect that Anteris Technologies Global Corp. will post -2.66 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. Lake Street Capital reissued a “buy” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Anteris Technologies Global in a research note on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $15.00.
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Read More
- Five stocks we like better than Anteris Technologies Global
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
